NPR Affiliate since 1985
Ozarks at Large Stories

UAMS Geriatric Science Team Developing Drug Based on Alzheimer's Risk Reduction Research

KUAF | By Jacqueline Froelich
Published July 12, 2021 at 12:02 PM CDT
  • Facebook
  • Twitter
  • LinkedIn
  • Email

Your browser doesn’t support HTML5 audio
UAMS Donald W. Reynolds Institute on Aging
Courtesy

A team of University of Arkansas for Medical Sciences lead by Distinguished Geriatrics Professor Sue Griffin are developing a drug, based on their published original DNA research, to reduce Alzheimer’s Diseaserisk.

Ozarks at Large StoriesHealthUAMSAlzheimer'sDementia
  • Facebook
  • Twitter
  • LinkedIn
  • Email
Jacqueline Froelich
Jacqueline Froelich is an investigative reporter and news producer for Ozarks at Large.
See stories by Jacqueline Froelich
Related Content
  1. Bolstering Alzheimer's Research
  2. UAMS Hosts Alzheimer's Seminar for Kids
  3. June is Alzheimer's Awareness Month
  4. Caring for Alzheimer's Caregivers
  5. Lawmakers Unanimously Back Act To Create Alzheimer's and Dementia Advisory Council